CT-P13 SC during COVID-19_graphical abstract_04Nov21.pdf (142.21 kB)
Download file

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and after the COVID-19 Era

Download (142.21 kB)
posted on 05.01.2022, 10:11 by Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, Rene Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, Toshifumi Hibi, Ken Takeuchi, Fernando Magro, Yoorim An, Dong-Hyeon Kim, SangWook Yoon, Walter Reinisch

Article full text

The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2022.